Genetically, lesion-confined mTOR-pathway mosaicism accounts for a substantial subset of FCD type II, while SLC35A2 mutations underlie mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE). This evidence concerns the gene MTOR and isolated focal cortical dysplasia type II.